The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR&Q Insurance Regulatory News (RQIH)

Share Price Information for R&Q Insurance (RQIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.20
Ask: 1.795
Change: -0.3025 (-16.81%)
Spread: 0.595 (49.583%)
Open: 2.20
High: 2.20
Low: 1.70
Prev. Close: 1.80
RQIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic & Trading Update

4 Apr 2023 07:00

RNS Number : 2372V
R&Q Insurance Holdings Ltd
04 April 2023
 

R&Q Insurance Holdings Ltd

 

Strategic Initiative to Separate Program Management and Legacy Insurance & Trading Update

 

4 April 2023

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q" or the "Group"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces that the Board of R&Q is reviewing strategic options to separate its Program Management business, Accredited, and its Legacy Insurance business. In addition, R&Q also provides a trading update on the Group's expected operating performance for the financial year ended 31 December 2022.

 

Strategic Initiative to Separate Accredited and Legacy Insurance

 

R&Q's Program Management business, Accredited, has grown significantly over the past three years, achieving record Gross Written Premium and Fee Income (excluding minority stakes in MGAs) of $1.8 billion and $80 million, respectively, in 2022. It is now one of the largest program managers globally.

 

Accredited relies on an 'A' credit rating to conduct business and historically relied on the financial strength of the broader Group to obtain its credit rating. However, given Accredited's current size and scale, R&Q believes it is in the best interests of R&Q's shareholders for Accredited to stand on its own. Therefore, the Board of R&Q is reviewing strategic alternatives to separate Accredited and Legacy Insurance, which will include a legal reorganisation followed by strategic transactions with third parties to achieve this objective. R&Q expects the separation will set each of Accredited and Legacy Insurance on more favourable footing to deliver profitable growth, each with their own appropriate capital structures.

 

The legal reorganisation is subject to regulatory and lender consents, which R&Q expects to obtain in Q2 2023.

 

Preliminary FY 2022 Trading Update

 

Based on preliminary and unaudited information, R&Q anticipates that it will realise a Pre-Tax Operating Profit (Loss) for the financial year ended 31 December 2022 of $(30)-(40) million, comprising $55-60 million in Program Management, $(55)-(60) million in Legacy Insurance and ~$(35) million in Corporate and Other, which is primarily interest expense.1

 

Program Management

 

Program Management is expected to realise a Pre-Tax Operating Profit of $55-60 million, driven by Gross Written Premium of $1.8 billion and Fee Income (excluding minority stakes in MGAs) of $80 million, which increased 80% and 78%, respectively, over the prior year. Pre-Tax Operating Profit includes $12 million of earnings from the Group's minority stake in Tradesman Program Managers, which has subsequently been sold to its controlling shareholder in Q1 2023.

 

Legacy Insurance

 

Legacy Insurance is expected to realise a Pre-Tax Operating (Loss) of $(55)-(60) million, driven by fewer transactions completed, with Gross Reserves Acquired of ~$70 million and net adverse development of ~3-4% of the Group's net reserves. We expect Reserves Under Management at year-end 2022 to be ~$400 million (~$1 billion as of January 2023). Prior to new accounting rules effective from 1 January 2023, the IFRS accounting regime allowed "Day-1 gains", which meant that a majority of a transaction's profits could be recorded upfront upon closing of the transaction. As a result, any net reserve development after a transaction had closed created heightened volatility in earnings but did not mean that the underlying returns of the transaction would not meet expectations when taking into account the Day-1 gain and investment income.

 

Corporate and Other

 

Corporate and Other is expected to be ~$(35) million. This comprises interest expense on debt, unallocated expenses and foreign exchange impact on reevaluation of net assets.

 

William Spiegel, Chief Executive Officer, commented:

 

"Our Program Management business, Accredited, has seen remarkable growth in Gross Written Premium, Fee Income and profitability over the past five years. Accredited currently partners with MGAs to offer over 80 different insurance programs and has over 200 reinsurance partnerships. Accredited has grown to become one of the largest program managers in the world and has the appropriate size and scale to stand on its own as an independent business. The Board has concluded that it is in shareholders' best interests to evaluate strategic options that allow for a separation of Accredited and Legacy Insurance. This will ensure both Accredited and Legacy Insurance have the strongest foundations from which to grow.

 

In Legacy Insurance, we continue to focus on transitioning to a fee-based and capital efficient model and remain confident that this will create a more profitable, sustainable and valuable business. While in 2022 we didn't complete as many transactions as in prior years, we maintained prudence in only pursuing deals that are profitable for both R&Q and Gibson Re. As announced on 6 January 2023, we have grown Reserves Under Management to in excess of $1 billion, starting from zero in the fourth quarter of 2021. While our Q4 2022 actuarial review process shows a need to strengthen reserves, it is important to note that the IFRS accounting regime recognised a large portion of total lifetime earnings at transaction close, which is a significant part of how we assess the overall profitability of historical legacy transactions.

 

Due to the planned separation, we expect to announce our final audited results in June 2023."

 

[1] Financial figures are estimates and therefore dependent on finalising full year 2022 results. Any reserve strengthening is a significant accounting estimate that involves management making assumptions and considering future events that are inherently uncertain. There is a risk that such judgements are not made in accordance with IFRS and thus there may be material differences once the auditors/actuaries have undertaken their review as part of the year end audit process which is yet to be completed.

 

Ends

 

Enquiries to:

 

R&Q Insurance Holdings Ltd

William Spiegel

Tel: +44 020 7780 5850

Tom Solomon

Tel: +44 020 7780 5850

 

Numis Securities Limited (Nominated Adviser, Joint Broker, and Financial Adviser)

Giles Rolls 

Tel: +44 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker and Financial Adviser)

Gary Antenberg

Nishant Amin

Andrew Tusa

Tel: +44 020 7260 1000

 

 

Tel: +1 212 526 9051

Tel: +44 020 7632 2322

Tel: +44 020 7632 2322

Fenchurch Advisory Partners (Financial Adviser)

Kunal Gandhi

Brendan Perkins

John Sipp

 

Howden Tiger (Financial Adviser)

Rob Bredahl

Leo Beckham

John Stamatis

 

FTI Consulting (Media Relations)

Tom Blackwell / Shipra Khanna

 

Tel: +44 020 7382 2222

Tel: +44 020 7382 2222

Tel: +1 917 603 2932

 

 

Tel: +1 646 685 4937

Tel: +44 079 276 4458

Tel: +1 646 685 4943

 

Tel: +44 020 3727 1051

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU, and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This announcement contains inside information as stipulated under the UK market abuse regulation no 596/2014, which is part of English law by virtue of the European (withdrawal) act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFXLLBXZLEBBE
Date   Source Headline
7th May 20207:00 amRNSNotice of General Meeting and Posting of Circular
6th May 20203:51 pmRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
29th Apr 20207:00 amRNSSignificant new investment in the Group
24th Apr 20202:05 pmRNSTransaction in Own Shares
24th Apr 20207:00 amRNSLoss Portfolio Transfer
23rd Apr 20204:04 pmRNSTransaction in Own Shares
22nd Apr 20205:35 pmRNSTransaction in Own Shares
21st Apr 20203:00 pmRNSTransaction in Own Shares
17th Apr 20205:13 pmRNSTransaction in Own Shares
15th Apr 20205:34 pmRNSTransaction in Own Shares
14th Apr 20207:00 amRNSAcquisition of ICI Insurance Company Limited
23rd Mar 20205:59 pmRNSTransaction in Own Shares
19th Mar 20204:52 pmRNSTransaction in Own Shares
19th Mar 20207:00 amRNSPart VII Transfer
18th Mar 20205:17 pmRNSTransaction in Own Shares
17th Mar 20205:43 pmRNSTransaction in Own Shares
17th Mar 20207:00 amRNSAccredited announces new underwriting program
16th Mar 20204:30 pmRNSTransaction in Own Shares
16th Mar 20207:00 amRNSShare Repurchase Programme
13th Mar 20207:00 amRNSR&Q and UK P&I Club agree transfer of liabilities
11th Feb 20208:00 amRNSProgram underwriting partnership
30th Jan 20207:00 amRNSPortfolio transfer
27th Jan 20207:00 amRNSAcquisition
16th Jan 20207:00 amRNSDirector Dealings
15th Jan 20207:00 amRNSDirectorate Change
14th Jan 20207:00 amRNSAllotment of Shares
13th Jan 20207:00 amRNSAppointment of Executive Deputy Chairman
30th Dec 201911:05 amRNSAcquisition
23rd Dec 20199:18 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSBoard Update
22nd Nov 201910:36 amRNSHolding(s) in Company
22nd Nov 20197:00 amRNSProgram underwriting partnership
28th Oct 20197:00 amRNSProgram underwriting partnership
8th Oct 20197:39 amRNSCompletion of acquisition
2nd Oct 20192:12 pmRNSResult of General Meeting
2nd Oct 20197:00 amRNSR&Q appoints Chief Restructuring Officer
25th Sep 20197:00 amRNSA.M. Best rating
9th Sep 20199:59 amRNSNotice of General Meeting and Return of Capital
6th Sep 20197:01 amRNSRetirement of Director
6th Sep 20197:00 amRNSInterim Results
22nd Aug 20197:00 amRNSLegacy agreement
21st Aug 20197:00 amRNSProgram underwriting partnerships
8th Aug 20197:00 amRNSR&Q provides legacy reinsurance for captive
12th Jul 20197:00 amRNSDirectors' Shareholding/Total Voting Rights
3rd Jul 20197:00 amRNSLoss Portfolio Transfer
1st Jul 20197:00 amRNSAcquisition
1st Jul 20197:00 amRNSTransaction with Phoenix Asset Management Partners
19th Jun 20194:49 pmRNSAnnual Report & Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.